Jounce names Murray CEO

Cancer immunotherapy play Jounce Therapeutics Inc. (Cambridge, Mass.) hired Richard Murray as CEO. Murray, formerly SVP of biologics and vaccines research at Merck & Co. Inc. (NYSE:MRK), succeeds inte...